Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025. This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961. Generally speaking, the NDAA governs Department of...
Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
Oct 2, 2024 | Fraud Investigations
The DOJ announced that John W. Kosolcharoen, founder and chief executive officer of Liveyon LLC and Genetech Inc., was sentenced to 3 years in federal prison for one count of introducing an unapproved new drug into interstate commerce with the intent to defraud and...
Oct 2, 2024 | Fraud Investigations
On September 30, 2024, the Department of Justice announced that Zishan Alvi, a 45-year-old Illinois resident, pleaded guilty to one count of wire fraud in connection with a COVID-19 testing case. According to court documents, Alvi owned and operated a laboratory in...
Sep 15, 2024 | DOJ, False Claims Act, Fraud Investigations, Health Care, Medicare and Medicaid
Late last week, the Department of Justice announced that Walgreen had agreed to pay over $106 million to resolve allegations that it violated the False Claims Act by billing government health care programs for prescriptions that were never dispensed. According to the...
Aug 12, 2024 | False Claims Act, federal investigations, Fraud Investigations
Last week, the DOJ announced two separate False Claims Act (FCA) settlements alleging the avoidance of import duties. Both were the result of qui tam whistleblower lawsuits. First, on August 8, 2024, the United States Attorney’s Office for the Eastern District of...
